Document Detail

The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice.
MedLine Citation:
PMID:  22123497     Owner:  NLM     Status:  Publisher    
Emerging findings suggested the efficacy of the cannabinoid CB1 receptor antagonist rimonabant (SR141716) in several pathological conditions included tumours. In this study we investigated in vitro the effects of SR141716 on viability and the molecular pathways of methylcholanthrene-induced fibrosarcoma (Meth-A) cells and in vivo its anti-tumour properties in Meth-A-bearing mice. We evaluated in vitro the effect of SR141716 on Meth-A cell viability by trypan blue staining assay. Cell cycle progression and apoptosis were assessed by flow cytometry. Protein expression was investigated by Western blot. The anti-tumour efficacy of SR141716 was evaluated in vivo monitoring weight increase and survival of Meth-A injected mice. SR141716 affects Meth-A cell viability inducing apoptosis and controls cell cycle progression by modulation of the levels of the cell cycle inhibitor p21waf, cyclins E, D1 and NF-kB molecules. Importantly, SR141716 affects AKT/pFoxO1 pathway which promotes cell survival and regulates the cell cycle. The molecular effects observed are accompanied by reduced COX2 expression and induction of the CB1 receptor expression. Finally, SR141716 was able to reduce the tumour size and prolong animal survival, when administered in vivo during tumour growth. Our findings shed light on a novel molecular pathway associated with control of tumour growth by SR141716 and confirm the anti-cancer and anti-inflammatory properties of this drug suggesting its potential applications in the treatment of cancer.
Anna Maria Malfitano; Chiara Laezza; Mario Galgani; Giuseppe Matarese; Alba D'Alessandro; Patrizia Gazzerro; Maurizio Bifulco
Related Documents :
8979047 - Expression of cyp2b1 in freshly isolated and proliferating cultures of epithelial rat l...
8447427 - Type ii pneumocyte hypertrophy without activation of surfactant biosynthesis after part...
16041037 - Factors associated with severe granulomatous pneumonia in mycobacterium tuberculosis-in...
18403327 - Bone marrow-derived cells and stem cells in lung repair.
165707 - Comparisons of major cell-surface proteins of normal and transformed cells.
18206137 - Differentiation of murine b cells induced by chondroitin sulfate b.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-11-22
Journal Detail:
Title:  Pharmacological research : the official journal of the Italian Pharmacological Society     Volume:  -     ISSN:  1096-1186     ISO Abbreviation:  -     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8907422     Medline TA:  Pharmacol Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011. Published by Elsevier Ltd.
Department of Pharmaceutical Sciences, University of Salerno, Via Ponte don Melillo, 84084 Fisciano, Salerno, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Diabetes Mellitus Following Liver Transplantation in Patients With Hepatitis C Virus: Risks and Cons...
Next Document:  The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease.